System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Linda E Carlson is an expert in Oncology at University of Calgary (Canada). Linda E Carlson has authored 283 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 5 of them ongoing. SLR score: 1,144 (community average: 125). How the SLR is computed.

LeadR Profile

Linda E Carlson University of Calgary Canada
1 144 ScienceLeadR Reputation 1144

Unlock

Register Login
Network Map

Oncology

Subspecialties: Psycology - Public Health - General Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1992 - 2026
Source: PubMed

University of Calgary

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 283

Citations

Citations: 25 464 1st author: 72 Last author: 92 Unique author: 14

Main journals

Psychooncology 17
J Clin Oncol 15
Integr Cancer Ther 14
American Psychological Association eBooks 8
Curr Oncol 8

Best Journals

J Clin Oncol 6
CA Cancer J Clin 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The Chemo-Gut Probiotic Trial Protocol: A Double-Blind Randomized Controlled Trial Investigating the Effects of a Multi-Strain Probiotic on Gut Microbiota, Gastrointestinal Symptoms, and Psychosocial Health Among Cancer Survivors.
PMID 42931362 — genes, rrna, clinical protocols, cancer survivors, bifidobacterium animalis, neoplasms, integrative oncology, multiple chronic conditions, signs and symptoms, probiotics, therapeutics, gastrointestinal microbiome, microbiota		Methods Protoc20260
Integrative options for the management of anxiety and depression in people with cancer.
PMID 42898778 — depression, yoga, neoplasms, aromatherapy, therapeutics		Front Oncol20260
Mindfulness and Tai Chi for Sleep, Fatigue, and Pain in Distressed People After Cancer Treatment: A Partially Randomized Patient-Preference Comparative Effectiveness Trial.
PMID 42748380 — cancer survivors, pain, sleep, neoplasms, signs and symptoms, mindfulness, fatigue, patient preference, therapeutics, tai ji		J Clin Oncol Top journal20260
A global assessment of the level of trust in information sources and adherence to COVID-19 related preventive health behaviors: cross-sectional survey study.
PMID 42414964 — trust, cross-sectional studies, disease outbreaks, health behavior, public health, covid-19, quarantine, demography, preventive health services		BMC Public Health20260
Healthcare Providers' Perspectives on Psychedelic-Assisted Therapies Across Clinical Contexts: "I Can Offer Medical Assistance in Dying, but I Can't Prescribe Psychedelics".
PMID 42396366 — medical assistance, neoplasms, psilocybin, ketamine, hallucinogens, health personnel, therapeutics		Glob Adv Integr Med Health20260

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4 Study Chair: 1

By phase:

N/A 15
Phase 2 2
Phase 3 1

By status:

Completed 8
Recruiting 3
Unknown 3
Active not recruiting 2
Not yet recruiting 2

By type:

Interventional 18

By Monocentric/Multicentric:

monocentric 12
multicentric2to4 5
multicentric5to9 1
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
MB PAT for Demoralization in Advanced Cancer ( PAT MIND ) Trial
NCT07791901 — pilots, neoplasms, psychotherapy, psilocybin, mindfulness, hallucinogens, therapeutics, psychological distress, demoralization		Phase 2Not yet recruiting2026
The Chemo Gut Probiotic Trial for Cancer Survivors
NCT06088940 — cancer survivors, neoplasms, multiple chronic conditions, signs and symptoms, capsules, probiotics, bifidobacterium, patient reported outcome measures, lactobacillus, therapeutics, bacteria, gastrointestinal microbiome, microbiota		N/ANot yet recruiting2023
Smartphone App Based Mindfulness Intervention for French and English Speaker Cancer Survivors
NCT05470010 — cancer survivors, meditation, neoplasms, multiple chronic conditions, smartphone, mindfulness, therapeutics, movement		N/AActive not recruiting2025
The Modulatory Role of Internet MBCT on Extracellular Vesicles and Distress in Cancer Patients Study Protocol
NCT04727593 — depression, interferon-gamma, genes, extracellular vesicles, internet, yoga, stress, physiological, mucin-1, neoplasms, telemedicine, prostate, biomarkers, mindfulness, walking, therapeutics, psychological distress, psychosocial intervention, adrenocorticotropic hormone, smoking, cognitive behavioral therapy		N/ARecruiting2021
Coping After Breast Cancer a Randomized Clinical Trial With Two Digital Interventions
NCT04480203 — quality of life, diagnostic self evaluation, breast neoplasms, stress, physiological, neoplasms, mindfulness, breast		N/ARecruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS